Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Free PMC article
Full text links

Actions

Share

Case Reports
.2013;7(1):42-5.

Epstein-barr virus-induced hemophagocytic lymphohistiocytosis

Affiliations
Case Reports

Epstein-barr virus-induced hemophagocytic lymphohistiocytosis

K Goudarzipour et al. Int J Hematol Oncol Stem Cell Res.2013.

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is one of the complications of Epstein-Barr virus (EBV) infection. Although the patients who have developed HLH following EBV have normal immune system, there are a few patients with EBV-induced immune deficiency who develop HLH as well. Here, we describe the case of a 10-year-old girl with neurological complications caused by EBV-induced HLH. The patient received rituximab, leading to weakening inflammation associated with EBV infection and suppression of disease through quick treatment.

Keywords: Epstein - Barr virus; Etanercept; Hemophagocytic lymphohistiocytosis; Infectious mononucleosis; Systemic inflammatory response syndrome; X-Linked lymphoproliferative disease.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ohga S, Nomura A, Takada H, Hara T. Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol. 2002;44:203–215. - PubMed
    1. Henter JI, Horne AC, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. PediatrBloodCancer. 2007;48:124–131. - PubMed
    1. Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. CritRevOncolHematol. 2002;44:259–2722. - PubMed
    1. Henter JI. Hemophagocytic lymphohistiocytosis (HLH): symptoms, signs and diagnosis of a rapidly fatal childhood disease. 2004. Available at:www.histio.org/site/apps/nl/content2.asp?c_kiKTL4PQLvF&b_1850031&ct_2592057. AccessedJanuary 25, 2007.
    1. Manual of Pediatric Hematology and Oncology. doi: 10.1016/B978-0-12-375154-6.00001-X. Copyright r 2011 Elsevier Inc. All rights reserved. - DOI

Publication types

Related information

LinkOut - more resources

Full text links
Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp